CIAAT Co., Ltd. (XKON:103660)
South Korea · Delayed Price · Currency is KRW 819.00
-80.00 (-8.90%)
At close: Feb 13, 2026
CIAAT Revenue
In the year 2014, CIAAT had annual revenue of 17.79B KRW with 36.03% growth.
Revenue
17.79B
Revenue Growth
+36.03%
P/S Ratio
0.28
Revenue / Employee
183.36M
Employees
97
Market Cap
4.93B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2014 | 17.79B | 4.71B | 36.03% |
| Dec 31, 2013 | 13.07B | 977.04M | 8.08% |
| Dec 31, 2012 | 12.10B | 6.28B | 108.06% |
| Dec 31, 2011 | 5.81B | -4.45B | -43.33% |
| Dec 31, 2010 | 10.26B | 1.65B | 19.19% |
| Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| A-One Alform | 22.35B |
| Bio Protech | 20.58B |
| Tide Co., Ltd. | 18.53B |
| Sevenbrau | 16.21B |
| QMC Co., Ltd. | 12.33B |
| Luxpia | 10.12B |
| Genotech | 7.28B |
| Micro-Nx | 7.14B |